Wells Fargo maintains Colgate-Palmolive at Equal-Weight, raises price target to $95 from $90

What happened

Wells Fargo kept its Equal-Weight rating on Colgate-Palmolive and raised its price target to $95 from $90, a 5.6% increase. The new target was roughly in line with the stock’s October 30 closing price of $95.29.

Confirmed

Global impact / market context

The higher target signals a modestly improved valuation view from Wells Fargo, but retaining Equal-Weight indicates the firm did not change its overall rating. Because the target was close to the cited closing price, this update alone points to limited implied price movement from that level.

Analyst inference

The three most recent analyst notes cited, published over 30 days, set targets between $90 and $105; Wells Fargo’s new $95 target sits near the bottom of that range. This spread shows analysts differ on Colgate-Palmolive’s potential value, without establishing which view will prove accurate.

Confirmed

What to watch

1. Watch for whether Wells Fargo changes its Equal-Weight rating or target again; a new view could alter its stated assessment of the stock’s potential relative performance. Analyst inference
2. Compare future analyst targets with the cited $90–$105 range and the stock’s price at the time; widening gaps could signal changing expectations, not guaranteed returns. Analyst inference
3. The article reports Wells Fargo’s raised target and retained rating, alongside recent targets from B of A Securities and JPMorgan; it gives no company operating results or forecast. Confirmed

Evidence

• Original source link unavailable